BIOLOGICS IND PREP
Accelerating Output for Series B Biotech
How our QA Clinic and deployed QMs guided a Seattle-based biologics firm to remediate 14 critical vendor audit findings in under 45 days, securing their IND submission timeline.
Before you submit: see how we handle your information in our California Privacy Notice.
EU QP MARKET ENTRY
Navigating the MHRA & EMA
A detailed breakdown of how Farbridge's QPPV services established a fully compliant local EU entity for an Australian gene-therapy manufacturer post-Brexit.
Before you submit: see how we handle your information in our California Privacy Notice.